BICYCLE THERAPEUTICS plc
Total Trades
99
Buys
0
Sells
71
Largest Trade
N/A
Insiders
11
Institutional Funds
77
Inst. Value
$1M+
Activist Filings
42
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Skynner Michael | CHIEF TECHNOLOGY O… | SELL | $15K–$50K | 955 | $23.81 | Apr 5, 2024 |
| Milnes Alistair | CHIEF OPERATING OF… | SELL | $15K–$50K | 955 | $23.81 | Apr 5, 2024 |
| Keen Nicholas | CHIEF SCIENTIFIC O… | SELL | $15K–$50K | 790 | $23.81 | Apr 5, 2024 |
| Crockett Nigel | CHIEF BUSINESS OFF… | SELL | $15K–$50K | 955 | $23.81 | Apr 5, 2024 |
| Thompson Travis Alvin | CHIEF ACCOUNTING O… | SELL | $1K–$15K | 152 | $23.81 | Apr 5, 2024 |
| Thompson Travis Alvin | Chief Accounting O… | GRANT | N/A | 16K | — | Jan 4, 2024 |
| Thompson Travis Alvin | Chief Accounting O… | SELL | $1K–$15K | 604 | $17.50 | Jan 4, 2024 |
| Keen Nicholas | Chief Scientific O… | GRANT | N/A | 28K | — | Jan 4, 2024 |
| Keen Nicholas | Chief Scientific O… | SELL | $15K–$50K | 3K | $17.50 | Jan 4, 2024 |
| Crockett Nigel | Chief Business Off… | GRANT | N/A | 22K | — | Jan 4, 2024 |
| Crockett Nigel | Chief Business Off… | SELL | $15K–$50K | 3K | $17.50 | Jan 4, 2024 |
| Milnes Alistair | COO | SELL | $15K–$50K | 3K | $17.50 | Jan 4, 2024 |
| Milnes Alistair | COO | GRANT | N/A | 39K | — | Jan 4, 2024 |
| Skynner Michael | CTO | GRANT | N/A | 28K | — | Jan 4, 2024 |
| Skynner Michael | CTO | SELL | $15K–$50K | 3K | $17.50 | Jan 4, 2024 |
| Lee Kevin | CEO | GRANT | N/A | 77K | — | Jan 4, 2024 |
| Lee Kevin | CEO | SELL | $100K–$500K | 9K | $17.50 | Jan 4, 2024 |
| Thompson Travis Alvin | Chief Accounting O… | SELL | $1K–$15K | 54 | $20.00 | Oct 5, 2023 |
| Keen Nicholas | Chief Scientific O… | SELL | $1K–$15K | 272 | $20.00 | Oct 5, 2023 |
| Crockett Nigel | Chief Business Off… | SELL | $1K–$15K | 442 | $20.00 | Oct 5, 2023 |
| Milnes Alistair | COO | SELL | $1K–$15K | 442 | $20.00 | Oct 5, 2023 |
| Lee Kevin | CEO | SELL | $15K–$50K | 1K | $20.00 | Oct 5, 2023 |
| Skynner Michael | CTO | SELL | $1K–$15K | 442 | $20.00 | Oct 5, 2023 |
| Thompson Travis Alvin | Chief Accounting O… | SELL | $1K–$15K | 61 | $25.10 | Jul 6, 2023 |
| Skynner Michael | CTO | SELL | $1K–$15K | 451 | $25.10 | Jul 6, 2023 |
| Milnes Alistair | COO | SELL | $1K–$15K | 451 | $25.10 | Jul 6, 2023 |
| Lee Kevin | CEO | SELL | $15K–$50K | 1K | $25.10 | Jul 6, 2023 |
| Keen Nicholas | Chief Scientific O… | SELL | $1K–$15K | 336 | $25.10 | Jul 6, 2023 |
| Crockett Nigel | Chief Business Off… | SELL | $1K–$15K | 451 | $25.10 | Jul 6, 2023 |
| Keen Nicholas | Chief Scientific O… | SELL | $1K–$15K | 319 | $21.11 | Apr 5, 2023 |
| Skynner Michael | CTO | SELL | $1K–$15K | 447 | $21.11 | Apr 5, 2023 |
| Milnes Alistair | COO | SELL | $1K–$15K | 447 | $21.11 | Apr 5, 2023 |
| Kalowski Lee | President and CFO | SELL | $1K–$15K | 376 | $21.11 | Apr 5, 2023 |
| Crockett Nigel | Chief Business Off… | SELL | $1K–$15K | 447 | $21.11 | Apr 5, 2023 |
| Lee Kevin | CEO | SELL | $15K–$50K | 1K | $21.11 | Apr 5, 2023 |
| Crockett Nigel | Chief Business Off… | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Crockett Nigel | Chief Business Off… | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Milnes Alistair | COO | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Milnes Alistair | COO | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Smethurst Dominic | Chief Medical Offi… | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Smethurst Dominic | Chief Medical Offi… | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Skynner Michael | CTO | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Skynner Michael | CTO | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Keen Nicholas | Chief Scientific O… | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Keen Nicholas | Chief Scientific O… | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Kalowski Lee | President and CFO | SELL | $50K–$100K | 2K | $29.06 | Jan 6, 2023 |
| Kalowski Lee | President and CFO | GRANT | N/A | 18K | — | Jan 6, 2023 |
| Lee Kevin | CEO | SELL | $100K–$500K | 6K | $29.06 | Jan 6, 2023 |
| Lee Kevin | CEO | GRANT | N/A | 58K | — | Jan 6, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 77 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3.0M | $1M+ | SH |
| Siren, L.L.C. | 2.0M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 1.7M | $1M+ | SH |
| GSK plc | 1.5M | $1M+ | SH |
| Candriam S.C.A. | 1.2M | $1M+ | SH |
| PRINCIPAL FINANCIAL GROUP INC | 1.1M | $1M+ | SH |
| BNP Paribas Asset Management Holding S.A. | 568K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 567K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 585K | $1M+ | SH |
| Birchview Capital, LP | 463K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 300K | $1M+ | SH (Call) |
| Jefferies Financial Group Inc. | 297K | $1M+ | SH |
| MOORE CAPITAL MANAGEMENT, LP | 275K | $1M+ | SH |
| Palo Alto Investors LP | 221K | $1M+ | SH |
| PINNACLE ASSOCIATES LTD | 190K | $1M+ | SH |
| PLATINUM INVESTMENT MANAGEMENT LTD | 185K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 148K | $1M+ | SH |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 135K | $500K+ | SH |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 135K | $500K+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 128K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Westfield Capital Management Company, L.P.
SC 13G/A · Mar 4, 2026
0.0%
0 shares
SC 13G · Mar 3, 2026
5.4%
2.7M shares
Westfield Capital Management Company, L.P.
SC 13G/A · Mar 3, 2026
0.0%
0 shares
Westfield Capital Management Company, L.P.
SC 13G/A · Mar 3, 2026
0.0%
0 shares
SC 13G · Feb 18, 2026
6.5%
3.2M shares
Westfield Capital Management Company, L.P.
SC 13G/A · Feb 11, 2026
6.0%
3.0M shares
SC 13G/A · Aug 15, 2025
10.0%
2.3M shares
Point72 Asset Management, L.P.
SC 13G/A · Aug 14, 2025
3.9%
1.9M shares
SC 13G/A · Aug 14, 2025
2.4%
1.2M shares
Point72 Asset Management, L.P.
SC 13G/A · May 15, 2025
7.8%
3.7M shares
SC 13G · May 15, 2025
5.6%
2.7M shares
SC 13G/A · May 15, 2025
5.7%
2.8M shares
SC 13G/A · Feb 14, 2025
6.7%
3.3M shares
Westfield Capital Management Company, L.P.
SC 13G · Feb 11, 2025
5.5%
2.6M shares
POINT72 ASSET MANAGEMENT, L.P.
SC 13G · Dec 20, 2024
8.9%
4.2M shares
Forbion Growth Opportunities Fund II Cooperatief U.A.
SC 13G · Dec 19, 2024
7.3%
3.5M shares
SC 13D/A · Dec 17, 2024
22.9%
10.9M shares
SC 13G/A · Nov 14, 2024
4.7%
2.3M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Jun 7, 2024
5.0%
2.3M shares
SC 13D/A · May 28, 2024
19.9%
9.4M shares
SC 13D · Apr 18, 2024
19.9%
7.7M shares
Ridgeback Capital Investments L.P. 66-0677421
SC 13G/A · Feb 14, 2024
2.2%
844K shares
BICYCLE THERAPEUTICS plc (Subject)
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G · Feb 14, 2024
5.2%
1.9M shares
SC 13G/A · Feb 14, 2024
9.3%
3.5M shares
SC 13G · Feb 12, 2024
12.8%
4.8M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 12, 2024
0.0%
0 shares
SC 13D/A · Jul 19, 2023
4.4%
1.5M shares
SC 13G/A · Feb 14, 2023
4.8%
1.4M shares
Ridgeback Capital Investments L.P. 66-0677421
SC 13G/A · Feb 14, 2023
7.6%
2.3M shares
Ridgeback Capital Investments L.P. 66-0677421
SC 13G/A · Feb 14, 2023
7.6%
2.3M shares
SC 13G/A · Feb 14, 2023
9.5%
2.8M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2023
5.1%
1.5M shares
SC 13G · May 2, 2022
5.2%
1.6M shares
Tybourne Capital Management (HK) Limited
SC 13D/A · Mar 14, 2022
4.8%
1.4M shares
Ridgeback Capital Investments L.P. 66-0677421
SC 13G/A · Feb 14, 2022
7.4%
2.2M shares
SC 13G/A · Feb 14, 2022
3.0%
870K shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Feb 11, 2022
5.8%
1.7M shares
SC 13G · Jan 27, 2022
5.1%
1.5M shares